Name: Mithra Pharmaceuticals SA (MITRA) Stock
Brand: Mithra Pharmaceuticals SA
Rating: 2 (3 reviews)

Question 1

What does MITRA do?

Accepted Answer

Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women’s health by offering new choices through innovation with a particular focus on contraception and menopause. The company is headquartered in Liege, Liege and currently employs 229 full-time employees. The company went IPO on 2015-06-30. The firm is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The firm provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The firm also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. The company offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The firm operates in more than 100 countries around the world and is headquartered in Liege, Belgium.

Question 2

Can you provide the latest stock price for Mithra Pharmaceuticals SA?

Accepted Answer

The current stock price of MITRA.BR is 0.216 EUR. The price decreased by -1.82% in the last trading session.

Question 3

What is the dividend status of Mithra Pharmaceuticals SA?

Accepted Answer

MITRA.BR does not pay a dividend.

Question 4

What is the ChartMill rating of Mithra Pharmaceuticals SA stock?

Accepted Answer

MITRA.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.

Question 5

Which stock exchange lists MITRA stock?

Accepted Answer

MITRA.BR stock is listed on the Euronext Brussels exchange.

Question 6

What is the Price/Earnings (PE) ratio of Mithra Pharmaceuticals SA (MITRA.BR)?

Accepted Answer

Mithra Pharmaceuticals SA (MITRA.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.42).

Question 7

What is Mithra Pharmaceuticals SA worth?

Accepted Answer

Mithra Pharmaceuticals SA (MITRA.BR) has a market capitalization of 14.93M EUR. This makes MITRA.BR a Nano Cap stock.

Mithra Pharmaceuticals SA (MITRA.BR) Stock Price, Forecast & Analysis

MITRA.BR Latest News, Press Relases and Analysis